Literature DB >> 2498925

5HT3 receptor antagonists block morphine- and nicotine- but not amphetamine-induced reward.

E Carboni1, E Acquas, P Leone, G Di Chiara.   

Abstract

The effect of two potent and specific antagonists of 5HT3 receptors, ICS 205-930 and MDL 72222, on the reinforcing properties of amphetamine, morphine and nicotine was studied in rats. Drug-induced reinforcement was assessed by measuring drug-conditioned place preference. ICS 205-930 and MDL 72222 dose-dependently reduced the place preference induced by morphine (1.0 mg/kg SC). At doses of 0.030 mg/kg SC the two antagonists completely blocked morphine-induced place preference while doses of 0.015 mg/kg SC significantly reduced it. ICS 205-930 and MDL 72222 at doses of 0.030 mg/kg SC also prevented the place preference induced by nicotine (0.6 mg/kg SC). In contrast, ICS 205-930 and MDL 72222 up to doses of 0.030 mg/kg SC failed to modify the place preference elicited by amphetamine (1.0 mg/kg SC). The results indicate that 5HT3 receptors are specifically involved in the reinforcing properties of morphine and nicotine.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2498925     DOI: 10.1007/bf00442245

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  13 in total

1.  A 5-HT receptor in the central nervous system, positively coupled with adenylate cyclase, is antagonized by ICS 205 930.

Authors:  A Dumuis; R Bouhelal; M Sebben; J Bockaert
Journal:  Eur J Pharmacol       Date:  1988-01-27       Impact factor: 4.432

2.  Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding.

Authors:  G J Kilpatrick; B J Jones; M B Tyers
Journal:  Nature       Date:  1987 Dec 24-31       Impact factor: 49.962

3.  Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine.

Authors:  P B Bradley; G Engel; W Feniuk; J R Fozard; P P Humphrey; D N Middlemiss; E J Mylecharane; B P Richardson; P R Saxena
Journal:  Neuropharmacology       Date:  1986-06       Impact factor: 5.250

Review 4.  Multiple serotonin receptors and their physiological significance.

Authors:  S J Peroutka; S H Snyder
Journal:  Fed Proc       Date:  1983-02

5.  Reinforcing properties of morphine and naloxone revealed by conditioned place preferences: a procedural examination.

Authors:  R F Mucha; S D Iversen
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

6.  Blockade of D-1 receptors by SCH 23390 antagonizes morphine- and amphetamine-induced place preference conditioning.

Authors:  P Leone; G Di Chiara
Journal:  Eur J Pharmacol       Date:  1987-03-17       Impact factor: 4.432

7.  Drug reinforcement studied by the use of place conditioning in rat.

Authors:  R F Mucha; D van der Kooy; M O'Shaughnessy; P Bucenieks
Journal:  Brain Res       Date:  1982-07-08       Impact factor: 3.252

8.  Pharmacologic characterization of nicotine-induced conditioned place preference.

Authors:  P J Fudala; K W Teoh; E T Iwamoto
Journal:  Pharmacol Biochem Behav       Date:  1985-02       Impact factor: 3.533

9.  Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats.

Authors:  G Di Chiara; A Imperato
Journal:  J Pharmacol Exp Ther       Date:  1988-03       Impact factor: 4.030

10.  MDL 72222: a potent and highly selective antagonist at neuronal 5-hydroxytryptamine receptors.

Authors:  J R Fozard
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-05       Impact factor: 3.000

View more
  32 in total

1.  Age-dependent effects of nicotine on locomotor activity and conditioned place preference in rats.

Authors:  James D Belluzzi; Alex G Lee; Heather S Oliff; Frances M Leslie
Journal:  Psychopharmacology (Berl)       Date:  2004-01-22       Impact factor: 4.530

2.  Effect of the 5-HT3 receptor antagonists, MDL72222 and ondansetron on morphine place conditioning.

Authors:  G A Higgins; N Joharchi; P Nguyen; E M Sellers
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

3.  Morphine-conditioned single-trial place preference: role of nucleus accumbens shell dopamine receptors in acquisition, but not expression.

Authors:  Sandro Fenu; Liliana Spina; Emilia Rivas; Rosanna Longoni; Gaetano Di Chiara
Journal:  Psychopharmacology (Berl)       Date:  2006-05-25       Impact factor: 4.530

4.  Aversion instead of preference learning indicated by nicotine place conditioning in rats.

Authors:  D E Jorenby; R E Steinpreis; J E Sherman; T B Baker
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

5.  Nicotine-conditioned single-trial place preference: selective role of nucleus accumbens shell dopamine D1 receptors in acquisition.

Authors:  Liliana Spina; Sandro Fenu; Rosanna Longoni; Emilia Rivas; Gaetano Di Chiara
Journal:  Psychopharmacology (Berl)       Date:  2005-12-10       Impact factor: 4.530

Review 6.  The non-antiemetic uses of serotonin 5-HT3 receptor antagonists. Clinical pharmacology and therapeutic applications.

Authors:  A J Greenshaw; P H Silverstone
Journal:  Drugs       Date:  1997-01       Impact factor: 9.546

7.  Effect of 5-HT3 receptor antagonists on the discriminative stimulus properties of morphine in rats.

Authors:  N Joharchi; E M Sellers; G A Higgins
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

Review 8.  The role of serotonin in memory: interactions with neurotransmitters and downstream signaling.

Authors:  Mohammad Seyedabadi; Gohar Fakhfouri; Vahid Ramezani; Shahram Ejtemaei Mehr; Reza Rahimian
Journal:  Exp Brain Res       Date:  2014-01-16       Impact factor: 1.972

9.  Clavulanic acid reduces rewarding, hyperthermic and locomotor-sensitizing effects of morphine in rats: a new indication for an old drug?

Authors:  Joseph A Schroeder; Nicholas G Tolman; Faye F McKenna; Kelly L Watkins; Sara M Passeri; Alexander H Hsu; Brittany R Shinn; Scott M Rawls
Journal:  Drug Alcohol Depend       Date:  2014-06-02       Impact factor: 4.492

10.  Co-administration of dextromethorphan with morphine attenuates morphine rewarding effect and related dopamine releases at the nucleus accumbens.

Authors:  Eagle Y-K Huang; Te-Chen Liu; Pao-Luh Tao
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-10-15       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.